Clinical Trial Detail

NCT ID NCT02097732
Title Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

melanoma

Therapies

Ipilimumab

Age Groups: adult

No variant requirements are available.